PMC:7736111 / 2032-2614
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
68 | 33-43 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
69 | 120-130 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
70 | 204-212 | Species | denotes | SARS-CoV | Tax:694009 |
71 | 452-465 | Species | denotes | coronaviruses | Tax:11118 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T16 | 91-364 | Sentence | denotes | Since it is now evident that SARS-CoV-2 employs the same set of receptors and host cells, previously utilized by SARS-CoV, various disease models were developed to understand the molecular networks implicated in viral evasion, host immune response, and immuno-pathogenesis. |
T17 | 365-546 | Sentence | denotes | Multiple factors and pathways are already known based on previous knowledge from other coronaviruses, which have shown promising potential as therapeutic targets (Tay et al., 2020). |